Predictive role of neostromal CD10 expression in breast cancer patients treated with neoadjuvant chemotherapy

Predictive role of neostromal CD10 expression in breast cancer patients treated with neoadjuvant chemotherapy

Background: The therapeutic strategy of invasive breast cancer is based on routine histopathological markers (estrogen-, progesterone receptor, HER2, Ki67) routinely evaluated in tumor cells. However, the assessment of cancer stroma could influence therapeutic strategies. Studies have shown that str...

Full description

Bibliographic Details
Main Authors:	Orsolya Olah, Edit Majlat, Renata Koszo, Zoltan Vereb, Andras Voros
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Pathology and Oncology Research
Subjects:	advanced breast cancer predictive factors CD10 neoadjuvant therapy neostroma
Online Access:	https://www.por-journal.com/articles/10.3389/pore.2022.1610598/full

Similar Items

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Huaqin Lin, et al.
Published: (2021-05-01)

Role of neoadjuvant chemotherapy in advanced carcinoma of the hypopharynx and larynx
by: Poonam Joshi, et al.
Published: (2017-01-01)

Patterns of failure in locally advanced female breast carcinoma treated with neoadjuvant chemotherapy followed by surgery and radiotherapy – A prospective study
by: Shilpi Adhikary, et al.
Published: (2023-03-01)

Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy
by: Aykut Elicora, et al.
Published: (2024-03-01)

The Correlation Between Computed Tomography Volumetry and Prognosis of Advanced Gastric Cancer Treated with Neoadjuvant Chemotherapy
by: Chen C, et al.
Published: (2020-02-01)

High post‐chemotherapy TIL and increased CD4+TIL are independent prognostic factors of surgically resected NSCLC following neoadjuvant chemotherapy
by: Wenxiao Jia, et al.
Published: (2023-02-01)

Short- and long-term outcomes of neoadjuvant chemotherapy compared with neoadjuvant chemoradiotherapy for locally advanced rectal cancer: an updated meta-analysis
by: Yue Guo, et al.
Published: (2025-02-01)

Neoadjuvant chemotherapy improves survival rate in advanced urothelial carcinoma
by: Chia-Chun Tsai, et al.
Published: (2013-04-01)

The comparative study for survival outcome of locally advanced cervical cancer treated by neoadjuvant arterial interventional chemotherapy or intravenous chemotherapy followed by surgery or concurrent chemoradiation
by: Yi Sun, et al.
Published: (2022-12-01)

Total Neoadjuvant Chemotherapy in Rectal Cancer: Current Facts and Future Strategies
by: Naohito Beppu, et al.
Published: (2023-01-01)

Neoadjuvant Treatment in Pancreatic Cancer
by: Atsushi Oba, et al.
Published: (2020-02-01)

Study of feasibility and efficacy of neoadjuvant chemotherapy in cases of locally advanced breast cancer
by: Arun V Dawle, et al.
Published: (2015-01-01)

The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer
by: Škof Erik, et al.
Published: (2016-09-01)

Colon cancer with extensive invasion of the abdominal wall treated with neoadjuvant chemotherapy and a free anterolateral thigh flap
by: Tsukasa Aritake, et al.
Published: (2022-08-01)

Evaluation of the Effects of Letrozole in Combination with Neoadjuvant Chemotherapy on Clinical Response Rate of Breast Cancer
by: Zahra Mozahheb, et al.
Published: (2021-03-01)

NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER
by: O. N. Churuksaeva, et al.
Published: (2016-02-01)

Relation Between CD8+T Lymphocyte Infiltration and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer
by: KONG Tiandong, et al.
Published: (2021-05-01)

History and current situation of neoadjuvant treatment for locally advanced esophageal cancer
by: Junyi Li, et al.
Published: (2021-09-01)

Assessment of Predictive Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
by: Mallika Tewari, et al.
Published: (2010-10-01)

Predictive Value of CD44v6 and EGFR Expression in Neoadjuvant Chemotherapy Sensitivity of Stage Ⅱ-Ⅲ Cervical Cancer
by: MAO Wanli, et al.
Published: (2022-09-01)

Prognostic Value of Interval Between the Initiation of Neoadjuvant Treatment to Surgery for Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy, Radiotherapy and Definitive Surgery
by: Xiang-Bo Wan, et al.
Published: (2020-08-01)

Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for initially unresectable locally advanced colon cancer: short-term outcomes of an open-label, single-centre, randomised, controlled, phase 3 trialResearch in context
by: Zi-Tong Zhang, et al.
Published: (2024-10-01)

Neoadjuvant chemotherapy in patients with stage IVB uterine serous carcinoma: a Turkish multicentric study
by: Mehmet Unsal, et al.
Published: (2023-12-01)

Neoadjuvant chemotherapy with paclitaxel/carboplatin/bevacizumab in advanced vulvar cancer: Time to rethink standard of care?
by: Madison R. Klavans, et al.
Published: (2020-11-01)

Disparities in neoadjuvant chemotherapy for pancreatic adenocarcinoma with vascular involvement
by: Nikhil Chervu, et al.
Published: (2024-08-01)

Tumor Microenvironment Modulation by Tumor-Associated Macrophages: Implications for Neoadjuvant Chemotherapy Response in Breast Cancer
by: Oner G, et al.
Published: (2025-02-01)

Neoadjuvant chemotherapy for patients with locally advanced penile cancer: an updated evidence
by: Xian-Yan-Ling Yi, et al.
Published: (2022-01-01)

The Impact of Neoadjuvant versus Adjuvant Chemotherapy on Survival Outcomes in Locally Advanced Breast Cancer
by: Farhad Ghasemi, et al.
Published: (2024-10-01)

Current Status and Controversies in Neoadjuvant Chemotherapy for Advanced Stage Ovarian Cancer: A Review
by: Jiaxi Li, et al.
Published: (2023-11-01)

Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer
by: Attila Paszt, et al.
Published: (2022-12-01)

Prognostic factors in patients with locally advanced breast cancer treated with neoadjuvant taxane-anthracycline combination chemotherapy
by: Chang-Eun Jang, et al.
Published: (2015-12-01)

Neoadjuvant chemotherapy may be the best neoadjuvant therapy modality for non-metastatic pancreatic cancer: a population based study
by: Jie Yang, et al.
Published: (2024-04-01)

Clinicopathological response assessment to neoadjuvant chemotherapy in locally advanced breast cancer- A rural population-based case series
by: Kailash Kumar Thakuria, et al.
Published: (2023-06-01)

A randomized phase 3 trial of total neoadjuvant therapy (induction chemotherapy, neoadjuvant chemoradiation, neoadjuvant chemotherapy, and surgery) vs. standard long-term chemoradiation therapy (neoadjuvant chemoradiation, surgery, and adjuvant chemotherapy) in locally advanced rectal cancer
by: Freshte Foroughi, et al.
Published: (2024-12-01)

Evaluation of pathological response to neoadjuvant chemotherapy in locally advanced cervical cancer
by: Li-Jun Wei, et al.
Published: (2024-07-01)

A Retrospective Study of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
by: Wang Y, et al.
Published: (2020-09-01)

Comparison of Neoadjuvant Chemotherapy Efficiency in Advanced Ovarian Cancer Patients Treated With Paclitaxel Plus Carboplatin and Intraperitoneal Bevacizumab vs. Paclitaxel With Carboplatin
by: Yin Tao, et al.
Published: (2022-03-01)

The Efficacy and Response Predictors of Platinum-Based Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer
by: Huang Y, et al.
Published: (2020-10-01)

Risk model and factors for prediction of response to neoadjuvant chemotherapy in patients with advanced gastric cancer-a two-center cohort study
by: Xian-Wen Liang, et al.
Published: (2023-01-01)

Impact of neoadjuvant FLOT treatment of advanced gastric and gastroesophageal junction cancer following surgical therapy
by: Attila Paszt, et al.
Published: (2023-04-01)